Biotech

All Articles

Relay drops 10% of personnel after earlier discharges in July

.Accuracy medication biotech Relay Rehabs is shedding about 10% of its staff in efforts to simplify ...

Pentixapharm scores $22M IPO to accommodation radiopharma tests

.Pentixapharm has brought in virtually 20 thousand europeans ($ 22 million) from an IPO, with the Ge...

Lundbeck faucets Charles Waterway for AI-enabled neuro drug invention

.Lundbeck has tapped Charles Stream Laboratories' expert system functionalities to aid the finding o...

Big pharma, biotech 'won't automatically be cooperative' in AI: S&ampP

.Significant Pharma is investing greatly in AI to lower development timetables as well as foster tec...

I &amp I biotech Triveni raises $115M for preclinical antibodies

.Triveni Biography has actually roped in $115 million in series B funds to advance preclinical antit...

IGM pivots from cancer cells to autoimmune, shaking up C-suite

.IGM Biosciences ended in 2013 laying off staff and also improving its cancer cells pipeline. Now, t...

Shattuck axes CD47 system over weak effectiveness records, gives up 40% of staff and loses Ono handle

.Shattuck Labs has pounded another nail in to the casket of CD47. After observing a "moderate" effec...

BioMarin goes Outdoor camping, striking RNA handle biotech

.BioMarin is actually including combustion to the R&ampD fire, blowing a complement with CAMP4 Thera...

Cash- strapped Gritstone starts look for important alternatives as cancer injection records underwhelm

.Gritstone biography has produced financiers to explore "possible value-maximizing techniques" after...

Kailera launches with $400M set A, 4 Chinese obesity drugs

.Kailera Therapies has launched into the considerably crowded excessive weight room along with a por...